Antiretroviral therapy coverage for PMTCT in Tajikistan
Tajikistan: Antiretroviral therapy coverage for PMTCT was 92.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Tajikistan, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Tajikistan stood at 92.0%.
Compared with earlier readings it is down 3.2% on the previous year and up 73.6% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Tajikistan peaked at 100.0% in 2022 and was at its lowest, 0.0%, in 2000.
Tajikistan ranks 22nd of 84 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Tajikistan, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 3.0% | +200.0% |
| 2008 | 8.0% | +166.7% |
| 2009 | 9.0% | +12.5% |
| 2010 | 15.0% | +66.7% |
| 2011 | 21.0% | +40.0% |
| 2012 | 29.0% | +38.1% |
| 2013 | 36.0% | +24.1% |
| 2014 | 53.0% | +47.2% |
| 2015 | 55.0% | +3.8% |
| 2016 | 60.0% | +9.1% |
| 2017 | 57.0% | -5.0% |
| 2018 | 80.0% | +40.4% |
| 2019 | 66.0% | -17.5% |
| 2020 | 78.0% | +18.2% |
| 2021 | 79.0% | +1.3% |
| 2022 | 100.0% | +26.6% |
| 2023 | 95.0% | -5.0% |
| 2024 | 92.0% | -3.2% |
Tajikistan compared with similar countries
- Tajikistan's 92.0% is above the median for lower middle income countries, which is 83.5%, 1.1× the median. (32 countries reporting)
- Tajikistan's 92.0% is above the median for Europe & Central Asia, which is 91.0%, 1.0× the median. (8 countries reporting)
Biggest year-on-year movements
Years where Antiretroviral therapy coverage for PMTCT in Tajikistan changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2007 | +200.0% | 1.0% | 3.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.1% | 0.0% | 9.0% | 10 |
| 2010s | 47.2% | 15.0% | 80.0% | 10 |
| 2020s | 88.8% | 78.0% | 100.0% | 5 |
Countries ranked near Tajikistan
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.6758 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0596 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6416 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Tajikistan?
- Antiretroviral therapy coverage for pmtct in Tajikistan was 92.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Tajikistan?
- The highest recorded value was 100.0% in 2022.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Tajikistan?
- The lowest recorded value was 0.0% in 2000.
- How does Tajikistan rank for antiretroviral therapy coverage for pmtct?
- Tajikistan ranks 22nd out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Tajikistan?
- Over the last ten years it is up 73.6%. The long-run trend across the full record is volatile.
- Where does this Tajikistan data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).